Recent Finacing
Recent Raise
Ascendant Dx develops and commercializes proteomics-based diagnostic tests, using a tear-based biomarker panel (MelodyDx) to distinguish malignant from benign breast masses and integrate findings with established diagnostic platforms.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
